BoF talks to Peter Philips, creative and image director of Christian Dior Makeup, about his personal and professional trajectory.
Nike Inc. gave Chief Executive Officer Mark Parker a stock award valued at almost 10 times his typical annual share grant, on the condition that he work for the sporting-goods company for the next five years.
BoF compiles the most important professional moves of the week.
The impact of the inaugural event remains to be seen, but buyers and designers alike are bullish on its potential.
Trench coat maker Burberry is reporting slowing sales amid weakening demand in Asia and a volatile American market.
Colin McDowell sits down with Azzedine Alaïa to discuss his life, his work and the recently unveiled exhibition 'Couture/Sculpture: Azzedine Alaïa in the History of Fashion.'
J. Crew Group Inc., seeking to win over more cost-conscious shoppers, is introducing a new brand that will sell apparel at lower prices.
BoF compiles the most important professional moves of the week.
Kate Spade & Co. rose the most in five months after an analyst at Cleveland Research Co. recommended buying the shares because of the brand’s growth potential.
It’s an event that buyers and designers have long clamored for, but it also exposes some pressure points in the industry about the high priority that fashion brands give to the European shows.
Alexander Wang, creative director of Balenciaga, is in talks on his future at the clothing label, parent company Kering SA has confirmed.
Iris van Herpen on the weird wonderland of creative possibilities in new technologies from nanorobotics to synthetic biology.
The Indian beauty retailer said on Wednesday its second-quarter profit nearly tripled, as improved operating efficiency and strong demand for premium beauty products boosted margins.
The US retailer is planning to spin off its pharmacy business in what would be one of the biggest-ever breakups in the healthcare industry, according to reports.
The jeweller edged up its near-term revenue and profitability targets as efforts to keep the brand affordable pay off.
The Ozempic maker raised its full-year outlook for the third time this year on Wednesday as its Wegovy pill beat third-quarter sales forecasts, boosting the Danish firm's bid to win back ground from US rival Eli Lilly.
The fragrance firm reported third-quarter core profit a touch above market expectations on Wednesday, and raised its full-year growth outlook but failed to impress investors.
Sales and profit from clothing and homeware remain below two years ago but ‘brand is in good health.’
Owner Four Marketing is transitioning the label from founder-led brand to a studio-driven platform, with Bullen’s debut collection scheduled for Autumn/Winter 2027 in Paris
The hairdresser and founder had a career spanning more than half a century, working with the likes of Princess Diana and Madonna.